Assessment of functional outcomes by Sheehan Disability Scale in patients with major depressive disorder treated with duloxetine versus selective serotonin reuptake inhibitors

ConclusionsTreatment with SSRIs and duloxetine improved functional impairment in patients with major depressive disorder. Higher SDS or 17‐item Hamilton Depression Rating Scale baseline scores predicted less probability of SDS improvement; female gender predicted better improvement in functional impairment at endpoint. © 2015 The Authors. Human Psychopharmacology: Clinical and Experimental published by John Wiley & Sons, Ltd.

Source: Human Psychopharmacology: Clinical and Experimental - July 1, 2015 Category: Psychiatry Authors: David V. Sheehan, Michele Mancini, Jianing Wang, Lovisa Berggren, Haijun Cao, Héctor José Dueñas, Li Yue Tags: Research Article Source Type: research